Tuberculosis in hospitalised patients with HIV: clinical characteristics, mortality, and implications from the STAMP trial.
暂无分享,去创建一个
S. Lawn | K. Fielding | J. V. van Oosterhout | E. Corbett | A. Gupta-Wright | Jurgens A. Peters | D. Wilson | H. Mwandumba | D. Grint | Melanie Alufandika-Moyo | L. Chiume
[1] G. Maartens,et al. Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study , 2019, PLoS medicine.
[2] J. Dorward,et al. Dolutegravir in sub-Saharan Africa: context is crucial. , 2019, The lancet. HIV.
[3] M. Mendelson,et al. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[4] S. Lawn,et al. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial , 2018, The Lancet.
[5] E. Corbett,et al. High HIV and active tuberculosis prevalence and increased mortality risk in adults with symptoms of TB: a systematic review and meta‐analyses , 2018, Journal of the International AIDS Society.
[6] S. Yi,et al. Social-support needs among adolescents living with HIV in transition from pediatric to adult care in Cambodia: findings from a cross-sectional study , 2018, AIDS Research and Therapy.
[7] R. Wilkinson,et al. HIV-Associated Mycobacterium tuberculosis Bloodstream Infection Is Underdiagnosed by Single Blood Culture , 2018, Journal of Clinical Microbiology.
[8] M. Mendelson,et al. Prognostic indicators in the World Health Organization’s algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis , 2018, AIDS Research and Therapy.
[9] G. Bernard,et al. Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial , 2017, JAMA.
[10] N. French,et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study , 2017, The Lancet. Infectious diseases.
[11] I. Sanne,et al. Does Disseminated Nontuberculous Mycobacterial Disease Cause False-Positive Determine TB-LAM Lateral Flow Assay Results? A Retrospective Review , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] S. Lawn,et al. Disseminated tuberculosis among hospitalised HIV patients in South Africa: a common condition that can be rapidly diagnosed using urine-based assays , 2017, Scientific Reports.
[13] K. Maitland,et al. Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa , 2017, The New England journal of medicine.
[14] K. Lakhoo,et al. Corrigendum: A UK wide cohort study describing management and outcomes for infants with surgical Necrotising Enterocolitis , 2017, Scientific Reports.
[15] R. Calderón,et al. Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis , 2017, Antimicrobial Agents and Chemotherapy.
[16] S. Lawn,et al. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort , 2017, BMC Medicine.
[17] J. V. van Oosterhout,et al. Challenges with targeted viral load testing for medical inpatients at Queen Elizabeth Central Hospital in Blantyre, Malawi. , 2017, Malawi medical journal : the journal of Medical Association of Malawi.
[18] S. Charalambous,et al. Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa , 2016, PloS one.
[19] R. Walensky,et al. Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial , 2016, BMC Infectious Diseases.
[20] Christian Burkhardt,et al. Quality Control of Motor Unit Number Index (MUNIX) Measurements in 6 Muscles in a Single-Subject “Round-Robin” Setup , 2016, PloS one.
[21] S. Lawn,et al. Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis , 2016, BMC Medicine.
[22] S. Lawn,et al. Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications , 2016, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[23] N. Ford,et al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis , 2016, Journal of the International AIDS Society.
[24] S. Lawn,et al. Rapid diagnosis of TB in HIV-positive in-patients with M. tuberculosis bacteraemia in sub-Saharan Africa. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[25] S. Lawn,et al. HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up , 2015, Medicine.
[26] S. Lawn,et al. Anemia, Blood Transfusion Requirements and Mortality Risk in Human Immunodeficiency Virus-Infected Adults Requiring Acute Medical Admission to Hospital in South Africa , 2015, Open forum infectious diseases.
[27] N. Ford,et al. Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. , 2015, The lancet. HIV.
[28] S. Lawn,et al. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis , 2015, AIDS.
[29] S. Abdulla,et al. Towards host-directed therapies for tuberculosis , 2015, Nature Reviews Drug Discovery.
[30] L. Guinness,et al. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial , 2015, The Lancet.
[31] F. Cobelens,et al. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study , 2015, BMC Medicine.
[32] Y. Madec,et al. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] Lawrence H. Moulton,et al. Point-of-Care Lateral Flow Assays for Tuberculosis and Cryptococcal Antigenuria Predict Death in HIV Infected Adults in Uganda , 2014, PloS one.
[34] M. Knapp,et al. Service Use, Charge, and Access to Mental Healthcare in a Private Kenyan Inpatient Setting: The Effects of Insurance , 2014, PloS one.
[35] Peter G. Smith,et al. Treatment Outcomes of New Tuberculosis Patients Hospitalized in Kampala, Uganda: A Prospective Cohort Study , 2014, PloS one.
[36] S. Chow,et al. Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] S. Lawn,et al. High Diagnostic Yield of Tuberculosis From Screening Urine Samples From HIV-Infected Patients With Advanced Immunodeficiency Using The Xpert MTB/RIF Assay , 2012, Journal of acquired immune deficiency syndromes.
[38] P. Munseri,et al. Test Characteristics of Urinary Lipoarabinomannan and Predictors of Mortality among Hospitalized HIV-Infected Tuberculosis Suspects in Tanzania , 2012, PloS one.
[39] T. Holtz,et al. Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. , 2011, The Lancet. Infectious diseases.
[40] S. Lawn,et al. Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1 , 2010, AIDS.